ES71
TEAS SECTION 71 RECEIVED
05/19/2026
Back to search
Official data from USPTO
DEV DRUG ELUTING VALVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DEV DRUG ELUTING VALVE
ST13
US500000079248468Class
10, 42, 44
Filing
79248468
Registration
5911143
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/20/2026
Trademark type
Word
Nice classes
10, 42, 44
Filing date
11/13/2018
Registration date
11/19/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2019
Last transaction
05/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Jena, DE
Examiner
ZAK, HENRY
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
devie medical GmbH
Representatives
Jabari A. Shaw Vorys, Sater, Seymour and Pease LLP
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus and instrumentsin particular drug-releasing catheter-based heart valve implants for the treatment and prevention of bacterial infections of the heart valves
Class 42
Scientific and technological servicesin particular research in the field of drug-coated heart valve implants
Class 44
Medical servicesin particular in the field of treatment and prevention of bacterial infections in the heart valves
Publications
History of USPTO decisions and trademark events.
31 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/19/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/05/2021
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
03/27/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/11/2020
FIMP
FINAL DISPOSITION PROCESSED
03/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/19/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
11/19/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/03/2019
PUBO
PUBLISHED FOR OPPOSITION
09/03/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/30/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/14/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/14/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/14/2019
ALIE
ASSIGNED TO LIE
07/31/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
07/23/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/23/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
07/23/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/23/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2019
RFNT
REFUSAL PROCESSED BY IB
03/16/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/26/2019
RFRR
REFUSAL PROCESSED BY MPU
02/26/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/19/2019
CNRT
NON-FINAL ACTION WRITTEN
02/18/2019
DOCK
ASSIGNED TO EXAMINER
02/15/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/27/2018
Continuous trademark protection
Get notified about every new filing that threatens DEV DRUG ELUTING VALVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.